Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
The British Journal of Radiology
|
December 18, 2019
Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas
Christina Hague, Marianne Aznar, Lei Dong, et al.
Lancet (London, England)
|
March 24, 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
David J Thomson, James M Price, Matthew Tyler, et al.
BMJ Open
|
February 26, 2025
APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trial
Finbar Slevin, Eleanor Mae Hudson, Florien W Boele, et al.
Clinical and Translational Radiation Oncology
|
December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
David J Thomson, Clare Cruickshank, Helen Baines, et al.
Physics and Imaging in Radiation Oncology
|
January 19, 2026
An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapy
Francesco Fracchiolla, Arturs Meijers, Ester Orlandi, et al.
The British Journal of Radiology
|
February 28, 2022
Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy
Neil G Burnet, Thomas Mee, Simona Gaito, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
The British Journal of Radiology
|
December 18, 2019
Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas
Christina Hague, Marianne Aznar, Lei Dong, et al.
Lancet (London, England)
|
March 24, 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
David J Thomson, James M Price, Matthew Tyler, et al.
BMJ Open
|
February 26, 2025
APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trial
Finbar Slevin, Eleanor Mae Hudson, Florien W Boele, et al.
Clinical and Translational Radiation Oncology
|
December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
David J Thomson, Clare Cruickshank, Helen Baines, et al.
Physics and Imaging in Radiation Oncology
|
January 19, 2026
An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapy
Francesco Fracchiolla, Arturs Meijers, Ester Orlandi, et al.
The British Journal of Radiology
|
February 28, 2022
Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy
Neil G Burnet, Thomas Mee, Simona Gaito, et al.
Page
of 5